Camille Duluc

Pharmacological targeting of the protein synthesis <scp>mTOR</scp> /4E‐ <scp>BP</scp> 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

Camille Duluc, Siham Moatassim-Billah, Mounira Chalabi‐Dchar et al. · EMBO Molecular Medicine · 2015 · 192 citations · Full text

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression

Victoire Gouirand, Tristan Gicquel, Evan C. Lien et al. · The EMBO Journal · 2022 · 64 citations · Full text

Pancreatic Cancer, Biochemistry, Medicine +5

Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16

Mounira Chalabi‐Dchar, Stéphanie Cassant‐Sourdy, Camille Duluc et al. · Gastroenterology · 2015 · 44 citations · Full text

Signal Transduction, Signaling Pathway, Pancreatic Cancer +11

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts

Siham Moatassim-Billah, Camille Duluc, Rémi Samain et al. · Oncotarget · 2016 · 38 citations · Full text

Chemoprevention Strategy, Somatostatin Analog Som230, Pathology +18

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages

Rémi Samain, Alexia Brunel, Thibault Douché et al. · Cellular and Molecular Gastroenterology and Hepatology · 2021 · 31 citations · Full text